We are live on
!
Find out more
MF
Magnetar Financial Portfolio holdings
AUM
$9.84B
1-Year Est. Return
190.64%
This Fund
S&P 500
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$3.94B
AUM Growth
+$20.3M
(+0.52%)
Cap. Flow
-$535M
Cap. Flow
% of AUM
-13.58%
Top 10 Holdings %
Top 10 Hldgs %
26.72%
Holding
614
New
169
Increased
81
Reduced
51
Closed
251
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$110M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$83M |
| 3 |
WRK
WestRock Company
WRK
|
+$55.4M |
| 4 |
SP
SP Plus Corporation
SP
|
+$51.4M |
| 5 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
+$48.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEWR
New Relic, Inc.
NEWR
|
+$98.3M |
| 2 |
Baxter International
BAX
|
+$91.4M |
| 3 |
ABCM
Abcam PLC
ABCM
|
+$80.5M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$74.8M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$74.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.91% |
| 2 | Financials | 7.44% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Technology | 4.72% |
| 5 | Energy | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Humana
HUM
$48B
| $160M | 4.07% |
349,813
+224,041
| +178% | +$110M |
|
2
Merck
MRK
$324B
| $152M | 3.87% |
1,396,487
+109,719
| +9% | +$11.4M |
|
3
Novartis
NVS
$297B
| $125M | 3.18% |
1,239,942
+440,244
| +55% | +$42.5M |
|
4
Albertsons Companies
ACI
$5.47B
| $90.5M | 2.3% |
3,934,756
-731,280
| -16% | -$16.2M |
|
5
Abbott
ABT
$177B
| $90M | 2.28% |
817,235
-215,863
| -21% | -$21.6M |
|
6
Zimmer Biomet
ZBH
$17.6B
| $89.8M | 2.28% |
737,720
-358,331
| -33% | -$40M |
|
|
WRK
7
DELISTED
WestRock Company
WRK
| $87.9M | 2.23% |
2,116,558
+1,441,471
| +214% | +$55.4M |
|
|
CVII
8
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $87.2M | 2.21% |
8,306,206
| – | – |
|
9
Elanco Animal Health
ELAN
$12.5B
| $86.2M | 2.19% |
5,786,812
-2,108,719
| -27% | -$23.9M |
|
10
Encompass Health
EHC
$11.4B
| $83.2M | 2.11% |
1,247,745
+187,012
| +18% | +$12.1M |
|
|
PXD
11
DELISTED
Pioneer Natural Resource Co.
PXD
| $83.2M | 2.11% |
370,069
+354,238
| +2,238% | +$83M |
|
|
SPLK
12
DELISTED
Splunk Inc
SPLK
| $83.2M | 2.11% |
546,078
+9,922
| +2% | +$1.48M |
|
|
TXNM
13
TXNM Energy Inc
TXNM
$6.45B
| $83M | 2.11% |
1,994,913
-102,900
| -5% | -$4.41M |
|
|
KRTX
14
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $64M | 1.62% |
202,165
+198,264
| +5,082% | +$38.5M |
|
15
McKesson
MCK
$97.1B
| $60M | 1.52% |
129,624
-1,037
| -0.8% | -$472K |
|
|
AMED
16
DELISTED
Amedisys
AMED
| $58.8M | 1.49% |
618,911
+11,051
| +2% | +$1.03M |
|
17
Cigna
CI
$76.4B
| $57.5M | 1.46% |
192,040
+146,547
| +322% | +$42.8M |
|
18
Capri Holdings
CPRI
$1.79B
| $56.6M | 1.44% |
1,126,547
-186,634
| -14% | -$9.31M |
|
|
SP
19
DELISTED
SP Plus Corporation
SP
| $52.5M | 1.33% |
+1,025,013
| New | +$51.4M |
|
20
GSK
GSK
$103B
| $52.2M | 1.32% |
1,407,679
-215,881
| -13% | -$7.75M |
|
21
Medtronic
MDT
$106B
| $52.2M | 1.32% |
633,234
-686,678
| -52% | -$52.3M |
|
|
OLK
22
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $51.5M | 1.31% |
+2,049,051
| New | +$48.2M |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $49M | 1.24% |
+834,390
| New | +$46.9M |
|
|
IMGN
24
DELISTED
Immunogen Inc
IMGN
| $48.3M | 1.23% |
+1,629,285
| New | +$32.4M |
|
|
CERE
25
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $43.2M | 1.1% |
+1,018,428
| New | +$29.3M |
|
Similar funds
HI
MPI
URS
FPAS
CCM
OAM
FCM
HL
Magnetar Financial's Q4 2023 Portfolio in Review
As of Q4 2023, Magnetar Financial held 614 positions worth $3.94B, up 0.52% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Magnetar Financial withdrew a net $535M in Q4 2023, closing 251 positions and reducing 51 holdings. Its most notable exit was New Relic, Inc., an estimated $98.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Magnetar Financial opened a new position in SP Plus Corporation worth $52.5M.
- Magnetar Financial's largest Q4 2023 buy was SP Plus Corporation: 1,025,013 shares worth $52.5M.
- Magnetar Financial added most to Humana in Q4 2023, an estimated $110M increase.
- Magnetar Financial's biggest Q4 2023 reduction was Medtronic, cutting an estimated $52.3M.
- Magnetar Financial fully exited New Relic, Inc. in Q4 2023, selling an estimated $98.3M.
- Magnetar Financial's ten largest holdings make up 27% of its $3.94B portfolio in Q4 2023.
- Magnetar Financial opened 169 new positions and closed 251 in Q4 2023.
- Magnetar Financial's portfolio value rose 0.52% quarter-over-quarter to $3.94B.
Based on Magnetar Financial's 13F filing for Q4 2023, filed 13 Feb 2024.